U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 6 of 6 results

Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (RACEMIC)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...
Status:
US Approved Rx (2018)
First approved in 1950

Class (Stereo):
CHEMICAL (ABSOLUTE)



Droxidopa (Northera, Chelsea Therapeutics) is a synthetic catecholamino acid precursor of norepinephrine indicated for the treatment of orthostatic dizziness or lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension (NO...